BioSpace News Archive

HeiQ Viroblock Tested Successfully Against Virus That Causes COVID-19

HeiQ Viroblock NPJ03 is among the first textile technologies in the world to be proven effective against SARS-CoV-2 in the laboratory.

June 8, 2020
·
4 min read
Biotech Beach

Mateon Announces an Expansion to its Pharmaceutical Manufacturing AI Camera Grid by Including Contact Tracing to Ensure Worker Safety

Mateon Therapeutics, Inc. – Mateon announced that EdgePoint AI, a division within Mateon, announced its decision to expand its manufacturing AI vision camera grid to encompass a contact tracing application which will monitor the spread of COVID-19 indoors.

June 8, 2020
·
6 min read
Business

CENTOGENE to Report First-Quarter 2020 Financial Results on June 15, 2020

Centogene N.V. announced that it will issue a press release reporting its financial results for the three months ended March 31, 2020 on Monday, June 15, 2020, and will host a conference call to discuss these results at 8 a.m. EST that day.

June 8, 2020
·
4 min read
Business

TriSalus Appoints Scott Davie As Chief Technology Officer

TriSalus Life Sciences, a company committed to transforming outcomes for patients with solid tumors, announces the appointment of Scott Davie to the role of Chief Technology Officer, deepening the company’s leadership capabilities as it builds an integrated therapeutic/drug delivery portfolio.

June 8, 2020
·
4 min read
Drug Development

Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR269A for Multiple Myeloma

PBCAR269A Targets BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma and is the Company’s Third Investigational Allogeneic CAR T Candidate Advanced to the Clinic

June 8, 2020
·
8 min read
Business

Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors

Affinia Therapeutics, an innovative gene therapy company with a platform for rationally designed adeno-associated virus vectors and gene therapies, announced the appointment of Elliott Sigal, M.D., Ph.D., to the company’s Board of Directors.

June 8, 2020
·
3 min read
Policy

Arch Biopartners Submits Investigational New Drug Application to the FDA for Metablok (LSALT peptide)

Arch Biopartners Inc. announced it has submitted an Investigational New Drug Application to the U.S. Food and Drug Administration for its lead drug Metablok to conduct a Phase II trial to prevent acute organ inflammation and injury experienced by patients with COVID-19.

June 8, 2020
·
4 min read
Deals

Nanobiotix Secures €10M in Non-Dilutive Financing

Nanobiotix has been able to maintain business continuity and drive key strategic priorities throughout the first half of 2020.

June 8, 2020
·
3 min read
Drug Development

Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease

Study meets primary endpoint demonstrating non-inferiority of roxadustat to darbepoetin in correction and maintenance of hemoglobin levels

June 8, 2020
·
9 min read
Deals

Kezar Announces Proposed Public Offering of Common Stock - June 08, 2020

Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

June 8, 2020
·
4 min read